Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane and Carboplatin in Triple Negative Metastatic Breast Cancer
NCT01207102Phase 2Terminated
- Sponsor
- Duke University
- Start
- Aug 2011
- Primary completion
- Jun 2014
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of nab-paclitaxel in breast cancer, sponsored by Duke University. Started Aug 2011; status: terminated.
02
Drugs
nab-paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01207102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01207102.